Corresponding Author: Alex H. Krist, MD, MPH, Virginia Commonwealth University, 830 E Main St, One Capitol Square, Sixth Floor, Richmond, VA 23219 (chair@uspstf.net).
Accepted for Publication: April 16, 2020.
The US Preventive Services Task Force (USPSTF) members: Alex H. Krist, MD, MPH; Karina W. Davidson, PhD, MASc; Carol M. Mangione, MD, MSPH; Michael J. Barry, MD; Michael Cabana, MD, MA, MPH; Aaron B. Caughey, MD, PhD; Katrina Donahue, MD, MPH; Chyke A. Doubeni, MD, MPH; John W. Epling Jr, MD, MSEd; Martha Kubik, PhD, RN; Gbenga Ogedegbe, MD, MPH; Lori Pbert, PhD; Michael Silverstein, MD, MPH; Melissa A. Simon, MD, MPH; Chien-Wen Tseng, MD, MPH, MSEE; John B. Wong, MD.
Affiliations of The US Preventive Services Task Force (USPSTF) members: Fairfax Family Practice Residency, Fairfax, Virginia (Krist); Virginia Commonwealth University, Richmond (Krist); Feinstein Institute for Medical Research at Northwell Health, Manhasset, New York (Davidson); University of California, Los Angeles (Mangione); Harvard Medical School, Boston, Massachusetts (Barry); University of California, San Francisco (Cabana); Oregon Health & Science University, Portland (Caughey); University of North Carolina at Chapel Hill (Donahue); Mayo Clinic, Rochester, Minnesota (Doubeni); Virginia Tech Carilion School of Medicine, Roanoke (Epling Jr); Temple University, Philadelphia, Pennsylvania (Kubik); New York University, New York, New York (Ogedegbe); University of Massachusetts Medical School, Worcester (Pbert); Boston University, Boston, Massachusetts (Silverstein); Northwestern University, Evanston, Illinois (Simon); University of Hawaii, Honolulu (Tseng); Pacific Health Research and Education Institute, Honolulu, Hawaii (Tseng); Tufts University School of Medicine, Boston, Massachusetts (Wong).
Author Contributions: Dr Krist had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The USPSTF members contributed equally to the recommendation statement.
Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described at https://www.uspreventiveservicestaskforce.org/Page/Name/conflict-of-interest-disclosures. All members of the USPSTF receive travel reimbursement and an honorarium for participating in USPSTF meetings. Dr Barry reported receiving grants and personal fees from Healthwise.
Funding/Support: The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.
Role of the Funder/Sponsor: AHRQ staff assisted in the following: development and review of the research plan, commission of the systematic evidence review from an Evidence-based Practice Center, coordination of expert review and public comment of the draft evidence report and draft recommendation statement, and the writing and preparation of the final recommendation statement and its submission for publication. AHRQ staff had no role in the approval of the final recommendation statement or the decision to submit for publication.
Disclaimer: Recommendations made by the USPSTF are independent of the US government. They should not be construed as an official position of AHRQ or the US Department of Health and Human Services.
Additional Contributions: We thank Justin Mills, MD, MPH (AHRQ), who contributed to the writing of the manuscript, and Lisa Nicolella, MA (AHRQ), who assisted with coordination and editing.
Additional Information: The USPSTF makes recommendations about the effectiveness of specific preventive care services for patients without obvious related signs or symptoms. It bases its recommendations on the evidence of both the benefits and harms of the service and an assessment of the balance. The USPSTF does not consider the costs of providing a service in this assessment. The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision-making to the specific patient or situation. Similarly, the USPSTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms.
6.Curry
SJ , Krist
AH , Owens
DK ,
et al; US Preventive Services Task Force. Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: US Preventive Services Task Force recommendation statement.
JAMA. 2018;320(18):1899-1909. doi:
10.1001/jama.2018.16789PubMedGoogle ScholarCrossref 10.Hedegaard
H , Miniño
AM , Warner
M . Drug overdose deaths in the United States, 1999-2017.
NCHS Data Brief. 2018;(329):1-8.
PubMedGoogle Scholar 15.Nargiso
JE , Ballard
EL , Skeer
MR . A systematic review of risk and protective factors associated with nonmedical use of prescription drugs among youth in the United States: a social ecological perspective.
J Stud Alcohol Drugs. 2015;76(1):5-20. doi:
10.15288/jsad.2015.76.5PubMedGoogle ScholarCrossref 19.Jalling
C , Bodin
M , Romelsjö
A , Källmén
H , Durbeej
N , Tengström
A . Parent programs for reducing adolescent’s antisocial behavior and substance use: a randomized controlled trial.
J Child Fam Stud. 2016;25(3):811-826. doi:
10.1007/s10826-015-0263-yPubMedGoogle ScholarCrossref 21.Moyer
VA ; US Preventive Services Task Force. Primary care behavioral interventions to reduce illicit drug and nonmedical pharmaceutical use in children and adolescents: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med. 2014;160(9):634-639. doi:
10.7326/M14-0334PubMedGoogle ScholarCrossref 22.O’Connor
EA , Thomas
R , Robalino
S ,
et al. Interventions to Prevent Illicit and Nonmedical Drug Use in Children, Adolescents, and Young Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force: Evidence Synthesis No. 190. Agency of Healthcare Research and Quality; 2019. AHRQ Publication No. 19-05258-EF-1.
23.O’Connor
E , Thomas
R , Senger
CA , Perdue
L , Robalino
S , Patnode
C . Interventions to prevent illicit and nonmedical drug use in children, adolescents, and young adults: updated evidence report and systematic review for the US Preventive Services Task Force.
JAMA. Published May 26, 2020. doi:
10.1001/jama.2020.1432Google Scholar 24.Moyer
VA ; US Preventive Services Task Force. Primary care interventions to prevent tobacco use in children and adolescents: U.S. Preventive Services Task Force recommendation statement.
Ann Intern Med. 2013;159(8):552-557.
PubMedGoogle Scholar 25.Walkup
JT , Barlow
A , Mullany
BC ,
et al. Randomized controlled trial of a paraprofessional-delivered in-home intervention for young reservation-based American Indian mothers.
J Am Acad Child Adolesc Psychiatry. 2009;48(6):591-601. doi:
10.1097/CHI.0b013e3181a0ab86PubMedGoogle ScholarCrossref 27.Kim
HK , Leve
LD . Substance use and delinquency among middle school girls in foster care: a three-year follow-up of a randomized controlled trial.
J Consult Clin Psychol. 2011;79(6):740-750. doi:
10.1037/a0025949PubMedGoogle ScholarCrossref 29.Bannink
R , Broeren
S , Joosten-van Zwanenburg
E , van As
E , van de Looij-Jansen
P , Raat
H . Effectiveness of a web-based tailored intervention (E-health4Uth) and consultation to promote adolescents’ health: randomized controlled trial.
J Med Internet Res. 2014;16(5):e143. doi:
10.2196/jmir.3163PubMedGoogle Scholar 30.D’Amico
EJ , Parast
L , Shadel
WG , Meredith
LS , Seelam
R , Stein
BD . Brief motivational interviewing intervention to reduce alcohol and marijuana use for at-risk adolescents in primary care.
J Consult Clin Psychol. 2018;86(9):775-786. doi:
10.1037/ccp0000332PubMedGoogle ScholarCrossref 34.Foxcroft
DR , Callen
H , Davies
EL , Okulicz-Kozaryn
K . Effectiveness of the strengthening families programme 10-14 in Poland: cluster randomized controlled trial.
Eur J Public Health. 2017;27(3):494-500.
PubMedGoogle Scholar 35.Lee
CM , Neighbors
C , Kilmer
JR , Larimer
ME . A brief, web-based personalized feedback selective intervention for college student marijuana use: a randomized clinical trial.
Psychol Addict Behav. 2010;24(2):265-273. doi:
10.1037/a0018859PubMedGoogle ScholarCrossref 36.Sanci
L , Chondros
P , Sawyer
S ,
et al. Responding to young people’s health risks in primary care: a cluster randomised trial of training clinicians in screening and motivational interviewing.
PLoS One. 2015;10(9):e0137581. doi:
10.1371/journal.pone.0137581PubMedGoogle Scholar 41.Walton
MA , Resko
S , Barry
KL ,
et al. A randomized controlled trial testing the efficacy of a brief cannabis universal prevention program among adolescents in primary care.
Addiction. 2014;109(5):786-797. doi:
10.1111/add.12469PubMedGoogle ScholarCrossref 43.Malmberg
M , Kleinjan
M , Overbeek
G ,
et al. Effectiveness of the “Healthy School and Drugs” prevention programme on adolescents’ substance use: a randomized clustered trial.
Addiction. 2014;109(6):1031-1040. doi:
10.1111/add.12526PubMedGoogle ScholarCrossref 44.Knight
JR , Sherritt
L , Gibson
EB ,
et al. Effect of computer-based substance use screening and brief behavioral counseling vs usual care for youths in pediatric primary care: a pilot randomized clinical trial.
JAMA Netw Open. 2019;2(6):e196258. doi:
10.1001/jamanetworkopen.2019.6258PubMedGoogle Scholar 45.Screening, brief intervention, and referral to treatment (SBIRT). Substance Abuse and Mental Health Services Administration. Published September 15, 2017. Accessed August 27, 2019.
https://www.samhsa.gov/sbirt 48.Drug misuse prevention: targeted interventions [NICE guideline NG64]. National Institute for Health and Care Excellence. Published February 22, 2017. Accessed August 27, 2019.
https://www.nice.org.uk/guidance/ng64